Cervical Lesions Clinical Trial
Official title:
Clinical Evaluation of a Universal Adhesive in Noncarious Cervical Lesions
The purpose of this prospective clinical trial will be to evaluate the efficacy of an FDA
approved and marketed universal dental adhesive formulation in adult noncarious cervical
lesions using self-etch and selective etch approaches.
The hypothesis is that using a selective enamel etch with this universal adhesive will
enhance the restoration margin performance.
The purpose of this prospective clinical trial will be to evaluate the efficacy of a newly
formulated universal dental adhesive formulation in adult noncarious cervical lesions using
self-etch and selective etch approaches.
Thirty-three patients with at least two non-carious cervical lesions will receive one
restoration utilizing the self-etch universal adhesive with no separate enamel etching and
another restoration utilizing the universal adhesive and a a selective etch protocol in which
in which enamel is etched with 37% phosphoric acid.
After a screening/baseline visit at which the restorative procedures listed above will
conducted, the patient will be seen at recall visits after approximately 6, 12 and 24 months
to observe sensitivity, retention, marginal discoloration and marginal adaptation.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05281939 -
Multi-center Application of an AI System for Diagnosis of Cervical Lesions Based on Colposcopy Images
|
N/A |